Aprea Therapeutics, Inc. insider trading activity

Understanding Insider Activity at Aprea Therapeutics, Inc.

Welcome to our dedicated page for Aprea Therapeutics, Inc. (Nasdaq: APRE) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Aprea Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Aprea Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for APRE
TickerTime & DateFilingLink
APRE9:42:04 PM 10/25/2024
Duey Marc sold 6462 shares of Aprea Therapeutics, Inc. (APRE) for ~$29595
Filing
APRE12:30:13 PM, 10/24/2024
Gilad Oren(President/CEO) purchased 500 shares of Aprea Therapeutics, Inc. (APRE) for ~$1960
Filing
APRE12:30:55 PM, 10/17/2024
Duey Marc purchased 30000 shares of Aprea Therapeutics, Inc. (APRE) for ~$131700
Filing
APRE12:31:25 PM, 10/16/2024
Gilad Oren(President/CEO) purchased 250 shares of Aprea Therapeutics, Inc. (APRE) for ~$725
Filing
APRE12:30:47 PM, 10/16/2024
Duey Marc purchased 190 shares of Aprea Therapeutics, Inc. (APRE) for ~$490
Filing
APRE12:30:13 PM, 10/16/2024
Hamill John P.(SrVP/CFO/Prin Fin & Acct Ofcr) purchased 50 shares of Aprea Therapeutics, Inc. (APRE) for ~$123
Filing
APRE12:31:44 PM, 10/15/2024
Seizinger Bernd R. purchased 10000 shares of Aprea Therapeutics, Inc. (APRE) for ~$26800
Filing
APRE12:31:01 PM, 10/15/2024
Gilad Oren(President/CEO) purchased 1150 shares of Aprea Therapeutics, Inc. (APRE) for ~$2971
Filing
APRE12:30:16 PM, 10/15/2024
Hamill John P.(SrVP/CFO/Prin Fin & Acct Ofcr) purchased 450 shares of Aprea Therapeutics, Inc. (APRE) for ~$1174
Filing
APRE12:54:37 AM, 3/15/2024
Hamill John P.(SrVP/CFO/Prin Fin & Acct Ofcr) purchased 1010 shares of Aprea Therapeutics, Inc. (APRE) for ~$7362
Filing
APRE12:53:36 AM, 3/15/2024
Seizinger Bernd R. purchased 6860 shares of Aprea Therapeutics, Inc. (APRE) for ~$50009
Filing
APRE12:52:35 AM, 3/15/2024
HENNEMAN JOHN B III purchased 6860 shares of Aprea Therapeutics, Inc. (APRE) for ~$50009
Filing
APRE12:51:23 AM, 3/15/2024
Gilad Oren(President, CEO) purchased 2000 shares of Aprea Therapeutics, Inc. (APRE) for ~$14580
Filing
APRE8:34:28 PM, 6/8/2023
Seizinger Bernd R. purchased 10097 shares of Aprea Therapeutics, Inc. (APRE) for ~$36952
Filing

Discover the Complete Picture 🔒

Currently viewing just 6 of 14 insider filings.
Register now to dive deeper and explore the full dataset.